Jay Venkatesan's Net Worth

$196 Million

Estimate Recalculated Jul 2, 2024 08:55PM EST

Who is Jay Venkatesan?

Jay Venkatesan has an estimated net worth of $196 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., Targanta Therapeutics Corp., ALPINE IMMUNE SCIENCES, INC., Lion Biotechnologies, Inc., INSMED Inc, EXICURE, INC., Angion Biomedica Corp., and ACCESS PHARMACEUTICALS INC.

SEC CIK

Jay Venkatesan's CIK is 0001413350

Past Insider Trading and Trends

2021 was Jay Venkatesan's most active year for acquiring shares with 15 total transactions. Jay Venkatesan's most active month to acquire stocks was the month of August. 2011 was Jay Venkatesan's most active year for disposing of shares, totalling 14 transactions. Jay Venkatesan's most active month to dispose stocks was the month of April. 2007 saw Jay Venkatesan paying a total of $7,083,612.75 for 2,796,682 shares, this is the most they've acquired in one year. In 2021 Jay Venkatesan cashed out on 1,441,996 shares for a total of $9,931,353.98, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncothyreon Inc. No price found

EVP and General Manager

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 16
Form 4/A
∞
250K
$2.00
$500,000.00
250K
Sep 23
Form 4
∞
250K
$2.00
$500,000.00
250K
Sep 23
Form 4
—
0
—
—
0
Sep 4
Form 4
+8,080.43%
4.04M
—
—
4.09M
Aug 8
Form 3
—
0
—
—
0
Form 4
-6.04%
-201.00K
$2.72
-$546,900.00
3.13M
May 21
Form 4
-0.66%
-22.00K
$3.00
-$66,000.00
3.33M
May 16 - May 17
Form 4
-0.04%
-1.50K
$2.00
-$3,000.00
3.35M
May 10
Form 4
-0.02%
-600.00
$3.00
-$1,800.00
3.35M
May 6
Form 3
—
0
—
—
0
No matching records found

Targanta Therapeutics Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 2
Form 4
∞
2.67M
$10.00
$5,750,000.00
2.67M
Oct 15
Form 3
—
0
—
—
0
No matching records found

ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $26.52

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.20%
20.06K
$0.45
$9,028.35
238.13K
Jul 15
Form 4
—
0
—
—
0
Jan 3
Form 4
-13.33%
-400.00K
$9.40
-$3,760,000.00
2.6M
Sep 17
Form 4
+7.55%
15.3K
$3.86
$59,006.75
218.06K
Mar 30 - Mar 31
Form 4
—
0
—
—
0
Jan 4
Form 4
-20.24%
-812.78K
—
—
3.2M
Dec 22
Form 4
—
0
—
—
0
Jan 2
Form 4
+5.02%
190.88K
$5.37
$1,024,998.75
3.99M
Jan 18
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
∞
3.86M
—
—
3.86M
Jul 24
Form 3
—
0
—
—
0
No matching records found

Lion Biotechnologies, Inc. (IOVA) Snapshot price: $8.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Dec 5
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
No matching records found

INSMED Inc (INSM) Snapshot price: $29.08

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found